학술논문
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation
Document Type
Article
Author
Source
In Urology 2000 55(4):521-525
Subject
Language
ISSN
0090-4295